Oxford Science Enterprises (OSE), an investment company created to found, fund and build businesses via its partnership with the University of Oxford, has announced a further £250 million in funding.

The latest funds bring the total amount raised by OSE to more than £850 million since its inception in 2015.

The company stated that the funds significantly deepen its capital pool and will further enable it to identify scientific innovations from the University of Oxford, provide initial funding, hands-on support and access to expert networks and start-up infrastructure, to create new spinouts across life sciences, health tech and deep tech.

Alexis Dormandy, chief executive of OSE, said: "We are delighted to successfully complete this new fundraising.

“Attracting such high quality new and existing global investors reflects their enthusiasm for the strength of Oxford's science and our plans to drive positive impact from it.

“This fundraise comes at an exciting and pivotal time for OSE. We have built a talented team and proved our model of translating ground-breaking science into a diverse portfolio of transformational businesses.

“Our companies are making remarkable breakthroughs from cancer, heart failure and infectious diseases, to climate change, food security and quantum computing.

He added: “Over the next few years, we expect these companies will continue to make important progress; with our ongoing efforts, and the support of our shareholders, we look forward to helping them deliver impact and returns."

Share Story: